Company Overview

Company name: Purodiol
Description: Manufacturer of cannabis pharmaceutical products. The company’s product uses corn oil, allowing a 4 times greater bioavailability in relation to the use of powdered CBD, resulting in the reduction in its absorption time, intensification of the amount absorbed and increase of its levels, and also grows cannabis in its own organic and pesticide or herbicide or heavy metal free areas.
Year founded: 2015
Parent company: Isodiol International
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.purodiol.co.uk
Employees:
City: Alton
State: England
Country: United Kingdom
Region: Europe

Financial Highlights

Start up capital raised (USD Million):
Business status: Startup
Ownership: Acquired/Merged (Operating Subsidiary)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by Isodiol (CSE: ISOL) for $5 million on April 17, 2018. Total consideration includes $2 million in cash and $3 million in common stock.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 5.00
Last known valuation date: 07-Apr-2018